In the past two decades, the increasing knowledge on DCs and tumor biology has demonstrated that DCs protective role is highly dependent on their ability to effectively polarize CD4+ T cells towards the Th1 subset, to cross-present tumor antigens to CD8+ T cells and to both interact with and activate NK cells [15,25]. The gene discussed is CD8A; the disease is neoplasm.